Overview

Provides a timely summary of current therapies for chronic myelogenous leukemia (CML), discussing both basic pathophysiology and new experimental strategies. Compares interferon therapy with conventional chemotherapy.

Full Product Details

9780824799014

Table of Contents

Reviews

Coedited by the lead investigator of new drug trials for STI571, a new treatment for chronic myelogenous leukemia. Reported during the December, 2000 meeting of the American Society of Hematology, San Francisco, California, Dr. Talpaz called the pill the holy grail we are looking for in our business. this clinically-oriented book provides an excellent overview of the current medical management of CML at the turn of the century. It also provides information to understand the basis of some of the novel therapeutic modalities, which will reach clinical trials in the near future.highly recommended to all physicians dealing with CML. -Annals of Oncology

Author Information

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available